Brief Reports Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 15, 2000; 6(4): 585-587
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.585
Serological prevalence and risk factor analysis of hepatitis G virus infection in Hubei Province of China
De-Ying Tian, Dao-Feng Yang, Zheng-Gang Zhang, Hong-Bo Lei, Yuan-Cheng Huang, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan 430030, Hubei Province, China
Ning-Shao Xia, Unit of National Genetic Engineering, Xiamen University, Xiamen 361005, Fujian Province, China
De-Ying Tian, graduated from Tongji Medical University in 1975, and is now Director of the Department of Infectious Diseases, having 40 papers published.
Supported by a grant from the National 863 Plans, No 102-07-02-07
Correspondence to: De-Ying Tian, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan, 430030, Hubei Province, China. tianyawu@sina.com
Telephone: +86-027-83663326 Fax: +86-027-83662688
Received: January 26, 2000
Revised: February 20, 2000
Accepted: February 25, 2000
Published online: August 15, 2000

Abstract
Key Words: hepatitis G virus, enzyme linked immunoabsorbent assay, risk factors, polymeras e chain reaction, prevalence, transcription, genetic



INTRODUCTION

Hepatitis G virus (HGV),also known as GB virus C, is a recently cloned virus which may be associated with human non A-E hepatitis[1,2]. It is parenterally transmitted and usually coinfected or superinfected with hepatitis B or hepat itis C virus[3-5]. Some investigations have been reported on the serop revalence and molecular prevalence of HGV infection in different areas and diffe rent population[6-15]. Current infection of HGV is diagnosed by detectio n of HGV RNA, and past infection with HGV is detectable by testing anti-HGV env elope protein (E2)[16-17]. To investigate the prevalence of HGV in Hubei Province, a central area of the People’s Republic of China, ELISA and RT-PCR were employed to detect serum anti-HGV and HGV RNA in 1516 patients who were divided into 16 groups.

MATERIALS AND METHODS
Samples

One thousand five hundred and sixteen serum samples were obtained from 16 groups in Hubei Province, including 299 drug users (19.72%), 98 prostitutes (6.46%), 504 blood donors (33.25%), 61 hemodialysis patients (4.02%), 351 cases with viral hepatitis (23.15%), 41 with primary hepatocellular carcinoma (PHC, 2.70%), 51 with hemopathy (3.36%), 53 renal transplant recipients (3.49%) and 3 liver trans plant recipients (0.20%). 55 freshmen, nurses and doctors (3.63%) were employed as healthy controls.

Reagents and detecting methods

Serum HBV markers, HAV IgM, HEV IgM, and anti-HCV were detected by enzyme linked immunoabsorbent assay (ELISA). Anti-HGV was also detected by ELISA and the tes t kits were procured from Wantai Biological Preparation Co Ltd, Beijing. HGV RNA was assayed by reverse transcript polymerase chain reaction (RT-PCR) with the primers of 5’-UTR, and the kits were purchased from the Center of Hepatitis R ea gents, Beijing. Both anti-HGV and HGV RNA were simultaneously measured in the drug users, prostitutes, and healthy subjects. For other groups, HGV RNA was dete cted only when their anti-HGV was positive due to insufficient outlay.

Data statistics

All data were analyzed by means of the Chi-square test.

RESULTS
HGV infections in drug users and prostitutes

The positive rates of anti-HGV and HGV-RNA in drug users were 9.06% (34/375) and 27.20% (102/375); those in prostitutes were 38.77% (38/98) and 20.41% (20/98). The analysis of risk factors of HGV infections in drug users and prostitutes is listed in Tables 1 and 2.

Table 1 Positive rates of anti-HGV and HGV RNA in drug users and prostitutes.
nAnti-HGVHGV RNA
Drug users*
po2116.63 (14)27.96 (49)
iv16412.20 (20)32.92 (54)
Prostitutes
Non-addict229.09 (2)13.36 (3)
Addict7614.43 (36)22.36 (17)
Healthy group551.82 (1)0 (0)
Table 2 Risk factors of HGV infections in drug users.
Sex
Addiction duration
HBV infection
MaleFemale< 2 years≥ 2 yearsHBsAg (+)HBsAg (-)
Anti-HGV8.659.236.4812.5813.339.37
HGV RNA3.4632.849.7252.5616.6722.78

The positive rate of HGV RNA in intravenous drug users (IVDU) was higher than in oral users (χ2 = 4.36, P < 0.05). The positive rates of anti-HG V in the p rostitutes who were addicted to drugs were higher than those who were not (χ2 = 12.19, P < 0.01).

The statistical difference of anti-HGV positive rate was tested between users a ddicted for more than 2 years and users for less than 2 years (χ2 = 4.29, P < 0.05). The positive rate of HGV-RNA in female users was higher th an that in mal e users(χ2 = 11.55, P < 0. 01), that in the patients who were addicted for more t han 2 years was also higher than those addicted for less than 2 years (χ2 = 79.06, P < 0.01).

HGV infections in blood donors

Seven percent (29/417) of blood donors were found to be anti-HGV positive and 27.5% anti-HGV positive donors were detected to be HGV RNA positive.

HGV infections in the cases of PHC, hemodialysis, liver or kidney transplanta tion (Table 3)
Table 3 HGV infections in the cases of PHC, hemodialysis, liver or kidney tran splantation.
nAnti-HGVHGV RNA in anti-HGV (+) cases
Hemodialysis6113.11 (8/61)37.50 (3/8)
PHC414.80 (2/41)100.00 (2/2)
Liver transplantation333.30 (1/3)100.00 (1/1)
Kidney transplantation531.82 (1/53)0
Total1587.5 (12/158)50.00 (6/12)
HGV infections in the patients with hemopathy

Anti-HGV was detected in 6 (11.7%) out of 51 cases with hemopathy, among them, 4 cases with acute or chronic leukemia, one with aplasia anaemia and one with leukopenia. No HGV RNA was assayed in six anti-HGV positive cases.

HGV infections in the patients with viral hepatitis (Table 4)
Table 4 Positive rates of anti-HGV and HGV RNA in patients with viral hepatitis.
nAnti-HGVHGV RNA in anti-HGV (+) cases
Hepatitis A3514.29 (5/35)20.00 (1/5)
Hepatitis B21417.29 (37/214)35.14 (13/37)
Hepatitis C6214.52 (9/62)55.56 (5/9)
Hepatitis E254.00 (1/25)0
Hepatitis NA-E1526.67 (4/15)50.00 (2/4)
Total35115.05 (56/351)37.50 (21/56)

The positive rates of anti-HGV and HGV RNA did not correlate with the sex, age, duration, and severity of diseases. The mean levels of ALT and T-Bil in patients with hepatitis B whose anti-HGV was positive were higher than those whose anti-HGV was negative.

DISCUSSION

HGV is a new pathogenic agent which was discovered in 1995, its genome structur e resembles other flaviviruses containing a positive, single plus-strand RNA[1,2]. It has been demonstrated that the distribution of HGV is global[1,2,6-14]. The transmission route of HGV is similar to that of HBV and HCV[1,3,4,11,12]. The investigation on HGV infection rates in Hubei Province of China showed that the infection rates of HGV in cases with viral hepatitis , hemodialysis, hemopathy, transplantation, intravenous drug users (IVDU) and prostitutes were 15.05%, 13. 11%, 16.7%, 9.1% and 14.43%, higher than that in healthy controls (1.82%). The result indicate that HGV infection is common in China .

The infection rate of HGV in drug users varies widely on different documents with a range from 23.8% to 77.4%[7,18-20]. However, there is no contr ov ersy regarding the fact that drug addiction is a high risk factor for HGV infect ion. We found that the positive rate of HGV RNA in IVDU was higher than that in oral drug users (12.82% vs 2.97%, P < 0.05). This suggests that the un sterilized injections contribute to HGV transmission among IVDU.

It is known that sexual contact is a common route for horizontal transmission of HBV, HCV and HDV. Recently, sexual transmission of HGV has been demonstrated[18,21-25]. Our survey found that most of the prostitutes were also addicted to drugs, this may be one of reasons that they had a high HGV infection rate. HGV infection was found in 15.05% of patients with viral hepatitis. This is much higher among the blood donors in the same geographic area. However, there may be bias in this statistical inference, since blood donors who are found to be positive for HBsAg or for anti-HCV through screening programs are told not to donate blood. Thus, the low prevalence of HGV infection may represent a selection bias. This viewpoint was demonstrated by Handajani et al[14].

No agreement has been reached on the pathogenicity of HGV. Most of the recent in vestigations show that HGV infection in patients with hepatitis B and hepatitis C is not associated with any changes in indices of liver diseases, including serum ALT level, Knodell score or histology activity index (HAI)[25-28], and the consequences of hepatitis[27,29]. However, some reports inclu ding this paper found that HGV infection was associated with liver damage, even fulminant hepatitis[31,32]. So further prospective studies are needed to demonstrate its relative significance in causing hepatitis and other diseases.

High infection rates of HGV were also discovered in patients with hemodialysis, PHC, and transplantation. This result may be associated with the more transfusions received by these cases than healthy persons.

A conclusion which can thus be drawn from this study is that HGV infection is common in this area, and the drug users, prostitutes, transplant recipients, blood donors, patients with hemopathy, hemodialysis, and liver diseases are high risk groups for HGV infection.

Footnotes

Edited by Lu J proofread by Mittra S

References
1.  Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505-508.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol. 1996;48:60-67.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 10]  [Reference Citation Analysis (0)]
3.  Komatsu H, Fujisawa T, Inui A, Sogo T, Morinishi Y, Miyagawa Y, Inui M. GBV-C/HGV infection in children with chronic hepatitis C. J Med Virol. 1999;59:154-159.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Sauleda S, Reesink HJ, Esteban JI, Hess G, Esteban R, Guardia J. Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus. J Med Virol. 1999;59:45-51.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
5.  Yu JG, Hou XR, Pan W, Zhang GS, Zhou XM. PCR detection of hepatitis G virus RNA in sera and liver tissuees from patients with chronic hepatitis C. Shijie Huaren Xiaohua Zazhi. 1998;6:580.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Wu RR, Mizokami M, Cao K, Nakano T, Ge XM, Wang SS, Orito E, Ohba K, Mukaide M, Hikiji K. GB virus C/hepatitis G virus infection in southern China. J Infect Dis. 1997;175:168-171.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 39]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
7.  Löve A, Stanzeit B, Gudmundsson S, Widell A. Hepatitis G virus infections in Iceland. J Viral Hepat. 1999;6:255-260.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
8.  Desassis JF, Laperche S, Girault A, Kolko A, Bouchardeau F, Zins B, Poignet JL, Couroucé AM. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre. Nephrol Dial Transplant. 1999;14:2692-2697.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
9.  Liu HF, Muyembe-Tamfum JJ, Dahan K, Desmyter J, Goubau P. High prevalence of GB virus C/hepatitis G virus in Kinshasa, Democratic Republic of Congo: a phylogenetic analysis. J Med Virol. 2000;60:159-165.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
10.  Sathar MA, Soni PN, Naicker S, Conradie J, Lockhat F, Gouws E. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa. J Med Virol. 1999;59:38-44.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
11.  Elkayam O, Hassoba HM, Ferrell LD, Garcia-Kennedy R, Gish RG, Wright TL, Laffler T, Traylor D, Hunt G, Rosenthal P. GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplant. Pediatr Res. 1999;45:795-798.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
12.  Shimizu M, Osada K, Okamoto H. Transfusion-transmitted hepatitis G virus following open heart surgery. Transfusion. 1996;36:937.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 21]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
13.  Wong SB, Chan SH, Ren EC. Diversity of GB virus C/hepatitis G virus isolates in Singapore: predominance of group 2a and the Asian group 3 variant. J Med Virol. 1999;58:145-153.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
14.  Handajani R, Soetjipto MI, Suryohudoyo P, Adi P, Setiawan PB, Nidom CA, Soemarto R, Katayama Y, Fujii M, Hotta H. Prevalence of GB virus C/Hepatitis G virus infection among various populations in Surabaya, Indonesia, and identification of novel groups of sequence variants. J Clin Microbiol. 2000;38:662-668.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Isaacson AH, Bhardwaj B, Qian K, Davis GL, Kato T, Mizokami M, Lau JY. Hepatitis G virus infection in renal transplant recipients. J Viral Hepat. 1999;6:151-160.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 9]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
16.  Pilot-Matias TJ, Carrick RJ, Coleman PF, Leary TP, Surowy TK, Simons JN, Muerhoff AS, Buijk SL, Chalmers ML, Dawson GJ. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology. 1996;225:282-292.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 91]  [Cited by in F6Publishing: 96]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
17.  Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet. 1997;349:318-320.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 209]  [Cited by in F6Publishing: 218]  [Article Influence: 8.1]  [Reference Citation Analysis (0)]
18.  Wu JC, Sheng WY, Huang YH, Hwang SJ, Lee SD. Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes. J Med Virol. 1997;52:83-85.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
19.  Trisler Z, Seme K, Poljak M, Celan-Lucu B, Sakoman S. Prevalence of hepatitis C and G virus infections among intravenous drug users in Slovenia and Croatia. Scand J Infect Dis. 1999;31:33-35.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
20.  Anastassopoulou CG, Paraskevis D, Sypsa V, Psichogiou M, Katsoulidou A, Tassopoulos N, Skoutelis A, Malliori M, Hatzakis A. Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users. J Med Virol. 1998;56:246-252.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
21.  Sawayama Y, Hayashi J, Etoh Y, Urabe H, Minami K, Kashiwagi S. Heterosexual transmission of GB virus C/hepatitis G virus infection to non-intravenous drug-using female prostitutes in Fukuoka, Japan. Dig Dis Sci. 1999;44:1937-1943.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 17]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
22.  Yeo AE, Matsumoto A, Shih JW, Alter HJ, Goedert JJ. Prevalence of hepatitis G virus in patients with hemophilia and their steady female sexual partners. Sex Transm Dis. 2000;27:178-182.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
23.  Stark K, Doering CD, Bienzle U, Pauli G, Hamouda O, Engel AM, Schreier E. Risk and clearance of GB virus C/hepatitis G virus infection in homosexual men: A longitudinal study. J Med Virol. 1999;59:303-306.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
24.  Rey D, Fraize S, Vidinic J, Meyer P, Fritsch S, Labouret N, Schmitt C, Lang JM, Stoll-Keller F. High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus. J Med Virol. 1999;57:75-79.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
25.  Nerurkar VR, Chua PK, Hoffmann PR, Dashwood WM, Shikuma CM, Yanagihara R. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission. J Med Virol. 1998;56:123-127.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
26.  Slimane SB, Albrecht JK, Fang JW, Goodman Z, Mizokami M, Qian K, Lau JY. Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients. J Viral Hepat. 2000;7:51-55.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 8]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
27.  Césaire R, Martial J, Maier H, Kerob-Bauchet B, Bera O, Duchaud E, Brebion A, Pierre-Louis S. Infection with GB virus C/hepatitis G virus among blood donors and hemophiliacs in Martinique, a Caribbean island. J Med Virol. 1999;59:160-163.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
28.  Zhao XP, Yang DL, Wang BJ, Yang Y, Shen HX, Peng ZH, Hao LJ. Immunohis tochemical study of HGV expression in liver of patients with hepatitis G. Shijie Huaren Xiaohua Zazhi. 1998;6:586.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Bizollon T, Guichard S, Ahmed SN, Chevallier P, Ducerf C, Sepetjan M, Baulieux J, Trepo C. Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation. J Hepatol. 1998;29:893-900.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 15]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
30.  Tran A, Hastier P, Longo F, Yang G, Ouzan D, Durant J, Follana R, Buckley M, Saint-Paul MC, Doglio A. Lack of influence of hepatitis G virus infection on alcohol-related hepatic lesions. Scand J Gastroenterol. 1998;33:1209-1212.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 2]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
31.  Shu B, Dou XG, Li Y, Wang ZQ. Detection of HGVRNA in sera from patients with fulminant hepatitis in Shenyang. Zhonghua Liuxingbing Zazhi. 1998;19:168-169.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Chen XR, Xuan MX, Wu DW, Rong YM, Zhou YX, Wan BM, Wei YN, Fu CS. Study on hepatitis G virus infection. Zhonghua Liuxingbing Zazhi. 1999;20:85-87.  [PubMed]  [DOI]  [Cited in This Article: ]